Methods and uses involving genetic aberrations of NAV3 and aberrant expression of multiple genes

Details for Australian Patent Application No. 2009306260 (hide)

Owner Pharmatest Services Ltd.

Inventors Krohn, Kai; Ranki, Annamari; Carlsson, Emilia; Ovaska, Kristian; Hayry, Valtteri; Hautaniemi, Sampsa

Agent Spruson & Ferguson

Pub. Number AU-A-2009306260

PCT Pub. Number WO2010/046530

Priority 61/196,761 20.10.08 US

Filing date 19 October 2009

Wipo publication date 29 April 2010

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/046530 Priority application(s): WO2010/046530

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009306264-Modified fibrous product and method of producing the same

2009306252-Elevator system